Skip to main content
. Author manuscript; available in PMC: 2012 Nov 1.
Published in final edited form as: Diabetes Obes Metab. 2011 Nov;13(11):990–1000. doi: 10.1111/j.1463-1326.2011.01431.x

Figure 6.

Figure 6

Effect of exendin 9–39 on ERK1 phosphorylation in pancreas from control rats (A) and sciatic nerve from diabetic rats (B) incubated with variable concentrations of GLP-1, the effect of exendin 9–39 on ERK2 phosphorylation in pancreas from control rats (C) and sciatic nerve from diabetic rats (D) incubated with variable concentrations of GLP-1. White bars represent control tissue incubated with GLP-1, black bars diabetic tissue incubated with GLP-1 and grey bars tissue incubated with GLP-1+ Ex 9–39. Data are mean + SEM of n=4–7/group and represent the ratio of the intensity of bands corresponding to pERK1 and ERK1. *p<0.05, by unpaired Student t test for each concentration of GLP-1.